ArticleClinical rheumatology2022
Rituximab as a glucocorticoid-sparing agent in idiopathic inflammatory myopathies: a retrospective single-center cohort study.
Bugra Han Egeli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it